Antibody spectrum against the viral transactivator protein in patients with human immunodeficiency vires type 1 infection and Kaposi's sarcoma

Journal of Human Virology

Volumn 3, Issue 3, 2000, Pages 137-143

  Demirhan, Ilhan ^a   Chandra, Angelika ^a   Mueller, Friedericke ^a   Mueller, Hartmut ^b   Biberfeld, Peter ^c   Hasselmayer, Oliver ^a   Chandra, Prakash ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

^b DR HORST SCHMIDT KLINIKEN   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Anti tat IgG; HIV 1 infection; Kaposi's sarcoma; Passive immunization

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G; TRANSACTIVATOR PROTEIN;

ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; GERMINAL CENTER; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOBLAST; KAPOSI SARCOMA; LYMPH FOLLICLE; LYMPH NODE; PASSIVE IMMUNIZATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN;

ANTIBODIES, VIRAL; APOPTOSIS; EPITOPE MAPPING; GENE PRODUCTS, TAT; GERMINAL CENTER; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN G; LYMPH NODES; SARCOMA, KAPOSI;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033929347     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Clerici M, Stocks NI, Zajac RA, et al. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J Clin Invest 1989;84:1892-1899.
2. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
3. Weeks BS, Desaik K, Loewerstein PM, et al. Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein. J Biol Chem 1993;268:5279-5284.
4. Hynes RO. Integrins: a family of cell surface receptors. Cell 1987;48:549-554.
5. Viscidi RP, Mayur K, Lederman HM, Frankel AD. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 1989;246:1606-1608.
6. Chirmule N, Than S, Khan SA, Pahwa S. Human immunodeficiency virus Tat induces functional unresponsiveness in T cells. J Virol 1995;69:492-498.
7. Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995;268:429-431.
8. Westendorp MO, Frank R, Ochsenbauer C, et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995;375:497-500.
9. Katsikis, PD, Garcia-Ojeda ME, Torres-Roca JF, Greenwald DR, Herzenberg LA. HIV-1 type 1 Tat protein enhances activation but not Fas (CD95) induced peripheral blood T cell apoptosis in healthy individuals. Int Immunol 1997;9:835-841.
10. Demirhan I, Chandra A, Hasselmayer O, Chandra P. Intercellular traffic of human immunodeficiency virus type 1 transactivator protein defined by monoclonal antibodies. FEBS Lett 1999;445:53-56.
11. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984;32:219-229.
12. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F. Tat Protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature (Lond.) 1990;345:84-86.
13. Parmentier HK, van Wichen DF, Meyling FH, Goudsmit J, Schuurman HJ. Epitopes of human immunodeficiency virus regulatory proteins tat, nef, and rev are expressed in normal human tissue. Am J Pathol 1992;141:1209-1216.
14. Hauber J, Malim MH. And Cullen BR. Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. J Virol 1989;63:1181-1187.
15. Korber B, Kuiken C, Foley B, et al. Human retroviruses and AIDS. Los Alamos, NM: Los Alamos National Laboratory, 1998.
16. Cafaro I, Caputo A, Fracasso C, et al. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 tat protein vaccine. Nat Med 1999;5:643-650.
17. Gringeri A, Santagostino E, Muco-Perja M, et al. Safety and immimogenicity of HIV-1 tat toxoid in immunocompromised HIV-1-infected patients. J Hum Virol 1999;1: 293-298.
18. Cohen SS, Li C, Ding L, et al. Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge. Proc Natl Acad Sci U S A 1999;96:10842-10847.
19. Zagury JF, Sill A, Blattner W, et al. Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. J Hum Virol 1998;1:282-292.